Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)

PALATINE, Ill. and BRISTOL, Tenn., July 2 /PRNewswire-FirstCall/ -- Acura Pharmaceuticals, Inc. (Nasdaq: ACUR ) and King Pharmaceuticals, Inc. (NYSE: KG ) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (...

Palatin Technologies and King Pharmaceuticals Announce Plan To Present Results of Bremelanotide Phase 2b Studies in Men With Erectile Dysfunction

CRANBURY, N.J. and BRISTOL, Tenn., May 09, 2007 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and King Pharmaceuticals, Inc. today announced plans to present the results from two bremelanotide Phase 2b studies of men with erectile dysfunction (ED). The presenters are Jed Kaminetsky, MD, Cli...

Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide

CRANBURY, N.J., and BRISTOL, Tenn., May 22, 2007 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. and King Pharmaceuticals, Inc. reported today that data from Study 16 and Study 17 of the Phase 2B clinical trial program evaluating bremelanotide in men with erectile dysfunction (ED) were presen...

Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364

... king OF PRUSSIA, Pa., July 20 /PRNewswire/ -- Cytokine PharmaSciences, Inc. toda...-inflammatory and autoimmune therapeutics. The Company is headquartered in king of Prussia (near Philadelphia), Pennsylvania. A wholly owned subsidiary, Co...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

...Meeting RENO, Nev., June 25 /PRNewswire/ -- king Pharmaceuticals, Inc. (NYSE: KG ) today announce...ng of the College on Problems of Drug Dependence. king is also developing other pain medicines employing ... pain," said Eric Carter, Chief Science Officer of king Pharmaceuticals. "Our expectation is that these no...

Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrine's PS-Targeting Antibodies

...tudy by Dr. Huang, et al. was partly supported by the Gillson Longenbaugh and Meredith D. Chesler Foundations. Peregrine president and CEO Steven king commented, "It is noteworthy that these studies were primarily conducted using our new fully human antibodies, which could serve as the basis for the ...

Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial

...ment cycles, which had already exceeded the pre-defined number of objective tumor responses needed to expand the trial to the larger cohort." Mr. king added, "The tumor response data to date from this trial compares favorably to published studies with current standard-of-care lung cancer treatments, ...

Major Restless Legs Study Completes Enrollment With Support From MediciGlobal

... king OF PRUSSIA, Pa., March 31 /PRNewswire/ -- Successful and seamless completion of clinical trial enrollment requires careful forecasting of screened to ...

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

... king OF PRUSSIA, Pa., March 11 /PRNewswire/ -- CSL Behring has been informed by the U.S. Food and Drug Administration (FDA) that because RiaSTAP(TM) is the...

Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

...roway Topaz Kessler Meltzer & Check, LLP Darren J. Check, Esq. David M. Promisloff, Esq. 280 king of Prussia Road Radnor, PA 19087 1-888-299-7706 (toll free) or 1-610-667-7706 Or by e-mail at i...

Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk

...e included in this recall: Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, king Soopers, Smith's, Dillons, QFC, City Market, Foods Co., Jay C, Scott's, Owe...ocal banner names including Kroger, Ralphs, Fred Meyer, Food 4 Less, Fry's, king Soopers, Smith's, Dillons, QFC and City Market. In addition, Kroger associ...

Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial

...ted regularly for tumor response according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Peregrine president and CEO, Steven W. king noted, "We are very pleased that the sites were able to rapidly complete enrollment in the first part of this important Phase ll study. We look forwar...

Swedish in Seattle to Study Connections Between Preeclampsia and Migraine

...nter in Issaquah, Home Care Services, and the Swedish Physician Division - a network of about 40 primary-care and specialty clinics located throughout king County. In addition to general medical and surgical care, Swedish is known as a regional referral center, providing specialized treatment in areas suc...

REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted

...cs (Nasdaq: PTIE ) under license from DURECT, and Pain Therapeutics has, in turn, sublicensed the commercialization rights for this drug candidate to king Pharmaceuticals (NYSE: KG ). REMOXY, an investigational drug, is a unique, abuse-resistant, controlled release oxycodone for moderate-to-severe chron...

/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/

.... You are invited to join us at: The Hilton London Metropole Hotel, king Suite (3rd Floor, West Wing), 225 Edgware Road, London W2 1JU When: 21st .... You are invited to join us at: The Hilton London Metropole Hotel, king Suite (3rd Floor, West Wing), 225 Edgware Road, London W2 1JU When: 21st ...

Update on the SEAS Study

..., Head of Duke Clinical Research, Duke University) available via phone link. You are invited to join us at: The Hilton London Metropole Hotel, king Suite (3rd Floor, West Wing), 225 Edgware Road, London W2 1JU When: 21st July at 5.30pm for a 6pm start, BST OR The press conference will be Webca...

FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years

...information about AVANDIA, please see Patient Information. For further information on Avandia, please see full Prescribing Information. Bernadette king GlaxoSmithKline 215-751-3632 ...

Two Large, Independent Outcomes Trials Offer New Important Safety Information on Cardiovascular Effects of AVANDIA(R)

...out AVANDIA, please see Patient Information. For further information on AVANDIA, please see full Prescribing Information. Media Contacts: Bernadette king Doug Hochstedler (215) 751-7709 (646) 244-6600 ...

Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment

...etectable HCV-RNA (relapsers) versus those who did not (nonresponders) -- and by HCV genotype 1 subtype 1a versus 1b. Bruce R. Bacon, M.D., James F. king M.D. Endowed Chair in Gastroenterology, professor of internal medicine, and director, gastroenterology and hepatology, Saint Louis University School o...

Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP

...ass member. CONTACT: Schiffrin Barroway Topaz & Kessler, LLP Darren J. Check, Esq. Richard A. Maniskas, Esq. 280 king of Prussia Road Radnor, PA 19087 1-888-299-7706 (toll free) or 1-610-667-7706 Or by e-mail at info@sbtklaw.com ...

Low Acid Coffee Backed By Scientific Research

...alph's, Bristol Farms, Albertson's, Publix, Hannaford, Giant Foods, Kroger, king Soopers, D'Agostino's, Sprouts, king Supermarkets, Frys, Mollie Stone's, Ray's, Andronicos, Save Mart and Costco...

CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema

... Pivotal phase II/III study demonstrates C1-INH is effective treatment for acute HAE attacks king OF PRUSSIA, Pa., March 6 /PRNewswire/ -- CSL Behring has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA...

Mayo Clinic Proceedings January Tip Sheet

...of the article include James Cerhan, M.D., Ph.D.; Amit Sood, M.D.; Paul Limburg, M.D.; and Patricia Erwin, all of Mayo Clinic; and Imad Tleyjeh, M.D., king Fahd Medical City, Riyadh, Saudi Arabia. Researchers Issue Practical Guidelines for Workplace Drug Screening Commonly used in health care, wor...

Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)

...ed today by Pain Therapeutics (Nasdaq: PTIE ) and king Pharmaceuticals (NYSE: KG ); Pain Therapeutics is...n have sublicensed the commercialization rights to king Pharmaceuticals. According to Pain Therapeutics and king Pharmaceuticals, the FDA has agreed in writing tha...

Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System

...ults, will then be analyzed according to our primary and secondary intended uses by an outside biostatistical firm. Their results will be submitted to king and Spalding, who will assist in our preparation of the final PMA application. Unlike IDSI's prior PMA application, the new PMA application will not b...

CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema

... king OF PRUSSIA, Pa., Nov. 26 /PRNewswire/ -- CSL Behring announced today that it has reached the primary endpoint of a Phase III clinical trial of human p...

Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease

... On World COPD Day, Physicians Urged to Use Wider Screening Criteria for Alpha-1 Antitrypsin Deficiency king OF PRUSSIA, Pa., Nov. 14 /PRNewswire/ -- A new study finds that a higher than expected number of COPD and severe asthma patients had abnormal low leve...

Cytokine Announces Oral Efficacy of Anti-Cytokine Semapimod

... king OF PRUSSIA, Pa., Oct. 29 /PRNewswire/ -- Cytokine PharmaSciences, Inc. (CPSI) today announced development of an orally active form of semapimod, its s...

Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak

...la-recall.com . CONTACT: Schiffrin Barroway Topaz & Kessler, LLP Tobias L. Millrood, Esq. Hal J. Kleinman, Esq. 280 king of Prussia Road Radnor, PA 19087 1-888-348-6787 (toll free) or 1-610-822-0249 Or by e-mail at masstortinfo@sbtklaw.c...

Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help

...cts for the Tea Council of the USA, Inc.: Kevin Hughes Pollock Communications 646-277-8720 347-423-7559 (mobile) khughes@pollock-pr.com Barbara king Pollock Communications 212-941-1414 bking@pollock-pr.com ...

King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction

...l/ -- Palatin Technologies, Inc. (Amex: PTN ) and king Pharmaceuticals, Inc. (NYSE: KG ) announced today...d Chief Executive Officer of Palatin. Palatin and king plan to review the FDA comments in the overall con... has entered into collaborations with AstraZeneca, king Pharmaceuticals, and Tyco Healthcare Mallinckrodt....

Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors

... king OF PRUSSIA, Pa., Aug. 2 /PRNewswire/ -- Cytokine PharmaSciences, Inc. (CPSI) today revealed that recent experiments with its small-molecule MIF inhibi...

King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide

...etail at an upcoming scientific conference. About king Pharmaceuticals King, headquartered in Bristol, ... with the U.S. Securities and Exchange Commission. king does not undertake to publicly update or revise an...esults or events will not be realized. Contact king Pharmaceuticals, Inc., Bristol James E. Green, 42...

King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting

...n product in the treatment of hypertension. About king Pharmaceuticals King, headquartered in Bristol, ... with the U.S. Securities and Exchange Commission. king does not undertake to publicly update or revise an...esults or events will not be realized. Contact king Pharmaceuticals, Inc., Bristol James E. Green, 42...

King Pharmaceuticals Reports Efficacy of Altace 20mg And Efficacy of a Combination of Altace 20mg And Hydrochlorothiazide 25mg For 24-hour Blood Pressure Control

...ssure, dehydration and stomach irritation. About king Pharmaceuticals King, headquartered in Bristol, ... with the U.S. Securities and Exchange Commission. king does not undertake to publicly update or revise an...sults or events will not be realized. Contact king Pharmaceuticals Investor Contact: David E. Ro...

Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist

... Methodology This survey was conducted online within the United States by Harris Interactive on behalf of the Hypertension Education Foundation and king Pharmaceuticals, Inc. between January 4 and 17, 2007 among 1,245 adults, aged 45 and over, who have been diagnosed with hypertension. Figures for educ...